Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

Kai Li^#^{1

2}, Lei Ma^#³, Ye Sun^#⁴, Xiang Li^{1

2

5}, Hong Ren^{1

2}, Shou-Ching Tang⁶, Xin Sun^{7

8}

Affiliations

¹ Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China.
² Department of Thoracic Surgery and Oncology, Cancer Centre, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China.
³ Department of Anesthesiology and Perioperative Medicine, Operating Centre, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
⁴ Department of Anesthesiology and Operation, Operating Centre, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
⁵ Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
⁶ University of Mississippi Medical Center, Cancer Center and Research Institute, University of Mississippi, 2500 North State Street, Jackson, MS, 39216, USA. stang2@umc.edu.
⁷ Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China. dr_sun_endeavour@163.com.
⁸ Department of Thoracic Surgery and Oncology, Cancer Centre, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China. dr_sun_endeavour@163.com.

^# Contributed equally.

Published Erratum

Kai Li et al. Sci Rep. 2023.

. 2023 Aug 1;13(1):12450.

doi: 10.1038/s41598-023-39545-0.

Kai Li^#^{1

2}, Lei Ma^#³, Ye Sun^#⁴, Xiang Li^{1

2

5}, Hong Ren^{1

2}, Shou-Ching Tang⁶, Xin Sun^{7

8}

¹ Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China.
² Department of Thoracic Surgery and Oncology, Cancer Centre, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China.
³ Department of Anesthesiology and Perioperative Medicine, Operating Centre, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
⁴ Department of Anesthesiology and Operation, Operating Centre, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
⁵ Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
⁶ University of Mississippi Medical Center, Cancer Center and Research Institute, University of Mississippi, 2500 North State Street, Jackson, MS, 39216, USA. stang2@umc.edu.
⁷ Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China. dr_sun_endeavour@163.com.
⁸ Department of Thoracic Surgery and Oncology, Cancer Centre, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, 710061, Shaanxi, China. dr_sun_endeavour@163.com.

^# Contributed equally.

No abstract available

Figures

The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas.
Li K, Ma L, Sun Y, Li X, Ren H, Tang SC, Sun X. Li K, et al. Sci Rep. 2021 Sep 20;11(1):18587. doi: 10.1038/s41598-021-98131-4. Sci Rep. 2021. PMID: 34545132 Free PMC article.